Bristol-Myers Squibb is upgraded to Buy as its growth portfolio now offsets legacy declines, validating a bullish contrarian thesis. Read the latest analysis on the stock here.
Pagaya stock trades at deep-value territory despite its potential to beat estimates when it reports Q4 earnings. Click here ...
The Australian Medical Association (AMA) has renewed its call for changes to how private health insurers contract with ...
When a client has retirement assets spread across multiple accounts, advisors recommend strategizing for cash flow ...
Nikon has actually sold more cameras, but thanks to the success of budget models like the Z50 II and Z5 II, profit is down ...
Malibu Boats, Inc. (NASDAQ:MBUU) Q2 2026 Earnings Call Transcript February 5, 2026 Malibu Boats, Inc. misses on earnings expectations. Reported EPS is $-0.11251 EPS, expectations were $-0.03. Operator ...
ESCO Technologies Inc. (NYSE:ESE) Q1 2026 Earnings Call Transcript February 5, 2026 ESCO Technologies Inc. misses on earnings ...
ESCO Technologies Inc. (NYSE: ESE) (ESCO, or the Company) today reported its operating results for the first quarter ended December 31, 2025 (Q1 2026).
PAT surges 60%, debt reduced by ₹5,000 cr. Management outlines price hikes, coking coal impact, and a ₹36,000 cr IISCO expansion plan. Read full concall highlights.
Long-running Canadian powerhouse Nettwork Music Group has announced a management buyout from its existing investors, ...